MNI: PBOC Net Injects CNY57 Bln Via OMO Fri; Rates Unchanged

MNI: PBOC Sets Yuan Parity Higher At 7.1315 Fri; -0.52% Y/Y

CHINA PBOC CONDUCTS CNY59 BILLION VIA 7-DAY REVERSE REPOS FRI

CHINA SETS YUAN CENTRAL PARITY AT 7.1315 FRI VS 7.1285

MNI BRIEF: Fed's Bowman Wants A More Effective Discount Window

MNI BRIEF: Fed Risks Soft Landing If It Doesn’t Cut - Goolsbee

Japan Jun Core CPI +2.6% Y/Y; Energy Price Up

MNI BRIEF: Japan June Core CPI Rises 2.6% Vs. May +2.5%

CLARIFY: JAPAN JUNE SERVICES PRICES +1.7% Y/Y; MAY +1.6%

RPT-MNI: Canada Sticks To Fiscal Anchors, Spends Chunk Of Windfall

© 1982-2024 MNI. All rights reserved.
Terms | Privacy
Log Out
Free Trial

Medical Authorities Recommend AstraZeneca Vaccine Not Used For Over-65s

GERMANY

According to an FT story, the Standing Vaccine Commission at the Robert Koch Institute, Germany's top health agency, has recommended that the AstraZeneca/Oxford University COVID-19 vaccine is not given to those aged 65 or over as there is, according to the RKI, "insufficient data currently available to ascertain how effective the vaccination is above 65 years".

  • The German health ministry said in its study, of the 341 over 65s given the AZ vaccine, only one went on to contract COVID-19. However, the RKI stated that this sample size was not enough to give a statistically significant statement on the vaccine's efficacy.
  • This comes amidst a major row surrounding AstraZeneca, the EU, German newspaper Handelsblatt, and the German health ministry. Earlier this week Handelsblatt reported that according to an official at the German health ministry the AZ vaccine was only 8% effective against COVID-19 among the over-65s. This was swiftly rebutted by AZ.
  • A row then developed between AZ and the EU regarding a major shortfall in the supply of vaccines from AZ to the EU, which risks dragging the UK gov't in if the EU seeks to force AZ to divert doses from UK factories to the EU or if the EU puts export bans or other restrictions on Pfizer vaccines leaving the EU.
Homepagemarkets-real-timePolitical RiskPolitical Risk BulletBulletMarketsFixed Income BulletsForeign Exchange Bullets

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.